Welcome to my review of Jason Stutman’s presentation with the heading, The #1 Stock Of This Generation.
Jason introduces us to a tiny $5 stock that he says can transform every $500 you invest into $1.5 million.
After coming across this pitch, I sat through it in its entirety and dug a little deeper into what he was talking about before putting together this review. Keep reading to learn more about The #1 Stock of This Generation.
Before I start…
If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.
It’s helped me earn over $300,000 in the last 12 months alone:
Go here to see my no.1 recommendation for making money online
(This is a 100% free training)
![Is The #1 Stock Of This Generation Legit? [Jason Stutman] 7](data:image/svg+xml;nitro-empty-id=MjcyOjUyMg==-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNTU2IDY3IiB3aWR0aD0iNTU2IiBoZWlnaHQ9IjY3IiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
The #1 Stock Of This Generation Review
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Introduction to The #1 Stock Of This Generation
When Jason Stutman released his latest pitch, The #1 Stock Of This Generation, his main intention was to promote is investment advisory service, Technology and Opportunity.
It’s the same thing he did when he released another presentation titled New 5G Technology.
The difference is, in that pitch he was talking about investing in 5G technology companies while in this one, he is going on about a new breakthrough that can generate up to $15 trillion in new wealth in the next five years.
The breakthrough he is talking about is an anti-aging pill that reverses the effects of aging, which mostly involves eradicating the illnesses you’d normally associate with growing older.
How the anti-aging pill works
Jason says that so far, we have been approaching aging wrongly. According to him, doctors treat the individual illnesses rather than find the fundamental causes that cause aging; he attributes aging to old cells.
He explains that all cells have a lifespan i.e. they can only multiply a finite number of times. When they reach the end of their useful lives they become “zombie cells” and these are the ones that cause problems.
He goes on to say that zombie cells pump toxic chemicals into the body slowly poisoning other healthy cells converting some of them into zombie cells too.
Now, the anti-aging pill he is talking about contains compounds called senolytics that eradicate zombie cells thus minimizing their effect and slowing down the process of aging.
Anti-aging has piqued the interest of investors
Jason goes on to say that institutional investors like Vanguard, BlackRock, Goldman Sachs, Renaissance Technologies, and Charles Schwab are already involved — although that doesn’t usually mean much because those juggernauts tend to have their fingers in every pie.
What’s probably more significant is that Jeff Bezos and Peter Thiel have acquired a stake in companies working on anti-aging therapies.
Jason has narrowed it down to one tiny company that he claims is likely to grow bigger than Microsoft, McDonald’s, and Amazon if it can bring a successful pill to market and commercialize it.
He tells us that early investors in the tiny company can earn returns of up to 300,000%.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Who Is Behind The #1 Stock Of This Generation?
Jason Stutman is the chief investment strategist at Angel Publishing, which is an award-winning financial research firm that is based in Baltimore, Maryland.
Jason’s MO is uncovering big technological forces that have the potential to re-shape our society before they happen and finds ways to profit off of them before the mainstream media catches on.
He claims to have been one of the very first people to predict consumer robotics and the automation boom. In 2013, he recommended a tiny company (called iRobot) that would go on to earn investors a 1,600% return. He was also one of the “earliest adopters” of Bitcoin.
He is also the editor behind Topline Trader and Project Greenlight.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
How to invest in The #1 Stock Of This Generation?
In the introduction, I mentioned a small biotech firm that has found a way to produce anti-aging pills. Jason says that the only way to reveal its name and ticker symbol is to read his dossier, titled The #1 Stock of This Generation: How You Could Ride the End of Aging to Enormous Stock Returns.
The only way to get your hands on a free copy is by signing up for Jason’s advisory service, Technology and Opportunity.
However, you don’t have to read the report because after doing some research guided by the clues he shares during the pitch, I found out he is talking about Unity Biotechnology (Nasdaq: UBX).
It is a startup that was founded by Nathaniel David and Jan Van Deursen.
It develops senolytic-based therapies and Jeff Bezos and Peter Thiel are among its investors.
What you get when you subscribe to Technology and Profits
If you still want to subscribe to Technology and Profits, you will receive the following:
- 24/7 access to a custom web portal
- Special Situation updates
- Access to VIP Customer Success Team
You also receive three bonus reports, namely:
- The Robot Revolution: Three Stocks Poised for up to 900% Returns (Or More!)
- Space Billionaires: The #1 Stock to Own for 2020 and Beyond
- Ultranet Profits: Top Three Stocks for Riding the 5G Revolution.
Subscription Fee
The fees are $99/yr or $169 for a two-year subscription.
Refund Policy
The newsletter has a 6-month money-back guarantee.
RECOMMENDED: Go here to see my no.1 recommendation for making money online
Is The #1 Stock Of This Generation Legit?
The #1 Stock Of This Generation is a legit presentation.
Jason Stutman is an experienced investment analyst who’s made a career predicting trends hoping to cash in on them. In this presentation, he is predicting that one tiny company has cracked the code with regards to anti-aging and is set to introduce its revolutionary pill (who knows when).
The company is legitimate and some household-name investors have jumped on board.
Now, although the pitch is legit, it doesn’t mean that the prediction will come true because there are no guarantees when it comes to investing.
The #1 Stock Of This Generation Verdict
Although Jason Stutman requires you to subscribe to his newsletter (Technology and Profits) to reveal the name of his number one stock, I unearthed it and have revealed it to be Unity Biotechnology (Nasdaq: UBX).
Although scientists have made significant progress in their quest to understand what causes aging and ways to mitigate it, there is still a lot left to learn. It is a fledgling industry littered by startups working on different therapies and it is hard to tell when those drugs will be mass-produced.
There is no problem looking into nascent technologies because being a pioneer can be particularly lucrative. However, you should curb your expectations.
Before you leave
If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.
It’s helped me earn over $300,000 in the last 12 months alone:
Go here to see my no.1 recommendation for making money online
(This is a 100% free training)
![Is The #1 Stock Of This Generation Legit? [Jason Stutman] 7](data:image/svg+xml;nitro-empty-id=MzQyOjUyMg==-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNTU2IDY3IiB3aWR0aD0iNTU2IiBoZWlnaHQ9IjY3IiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
David Fortune has been the editor NoBSIMReviews.com since 2019. He is an expert at writing content on stock advisory services, side hustles, reviewing online business opportunities and many more topics. You can learn more about David on our about us page.